Oxford University Press

SHERPA: Yellow

People

  1. Drilon
    Drilon
  2. Motzer
    Motzer
  3. Mellinghoff
    Mellinghoff
  4. Shuman
    Shuman
  5. Rosenblum
    Rosenblum
  6. Dunkel
    Dunkel
  7. Karajannis
    Karajannis
  8. Saltz
    Saltz
  9. Souweidane
    Souweidane
  10. O'Reilly
    O'Reilly

Groups

  1. Department of Medicine (1996)
  2. Solid Tumor Oncology Division (1625)
  3. GSK Faculty (766)
  4. Survivorship Research (640)
  5. Population Sciences Research Program (616)
  6. Epidemiology and Biostatistics (466)
  7. Department of Pathology and Laboratory Medicine (416)
  8. Gastrointestinal Oncology Service (387)
  9. Genitourinary Oncology Service (367)
  10. Tow Center for Developmental Oncology (TCDO) (352)
Search Within
Formats
  1. Journal Article (2131)
  2. Meeting Abstract (2072)
  3. Book Section (192)
  4. Review (92)
  5. Editorial (84)
  6. Guidelines (36)
  7. Correspondence (26)
  8. Book Whole (18)
  9. Conference Paper (15)
  10. Research Letter (10)
Groups
  1. Department of Medicine (1996)
  2. Solid Tumor Oncology Division (1625)
  3. GSK Faculty (766)
  4. Survivorship Research (640)
  5. Population Sciences Research Program (616)
  6. Epidemiology and Biostatistics (466)

More Groups

People
  1. Lisa De Angelis (119)
  2. Alexander Drilon (108)
  3. Robert Motzer (96)
  4. Ingo Mellinghoff (93)
  5. Stewart Shuman (88)
  6. Marc Rosenblum (87)

More People

Years
  1. 2025 (129)
  2. 2024 (304)
  3. 2023 (320)
  4. 2022 (331)
  5. 2021 (323)
  6. 2020 (325)

More Years

Publications
  1. Annals of Oncology (1670)
  2. Neuro-Oncology (855)
  3. JNCI: Journal of the National Cancer Institute (492)
  4. Nucleic Acids Research (210)
  5. Clinical Infectious Diseases (140)
  6. American Journal of Clinical Pathology (106)

More Publications

Results (4676)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Efficacy and tolerability of modified dose intensive R- CODOX-M/IVAC for HIV-associated Burkitt (BL) (AMC 048)
    Meeting Abstract

    Noy, A.; Kaplan, L.; Lee, J.
    Annals of Oncology (2011)

    Fulltext@MSK | Save
  • Interim FDG-PET scanning for DLBCL should remain investigational
    Meeting Abstract

    Moskowitz, C. H.
    Annals of Oncology (2011)

    Fulltext@MSK | Save
  • Risk-adapted therapy using biopsy confirmation of abnormal interim FDG-PET for patients with advanced stage diffuse large B cell lymphoma (DLBCL), and exploratory evaluation of FLT-PET
    Meeting Abstract

    Moskowitz, C. H.; Schoder, H.; Hamlin, P. A.; Gerecitano, J. F.; Horwitz, S. M.; Matasar, M. J.; Moskowitz, A. J.; Noy, A.; Palomba, M.; Portlock, C. S.; more...
    Annals of Oncology (2011)

    Fulltext@MSK | Save
  • Updated results of a phase II trial of bendamustine in relapsed and refractory Hodgkin lymphoma
    Meeting Abstract

    Moskowitz, A. J.; Hamlin, P.; Gerecitano, J.; Horwitz, S.; Matasar, M.; Noy, A.; Palomba, M. L.; Portlock, C.; Straus, D.; Graustein, T.; more...
    Annals of Oncology (2011)

    Fulltext@MSK | Save
  • Atypical teratoid/rhabdoid tumor arising in a ganglioglioma
    Meeting Abstract

    Kleinschmidt-DeMasters, B.; Birks, D.; Hankinson, T.; Rosenblum, M.
    Journal of Neuropathology and Experimental Neurology (2011)

    Fulltext@MSK | Save
  • Glioneuronal tumor with neuropil-like islands (GTNI) is characterized by IDH1 R132H mutations
    Meeting Abstract

    Huse, J.; Nafa, K.; Ladanyi, M.; Hedvat, C.; Rosenblum, M.
    Journal of Neuropathology and Experimental Neurology (2011)

    Fulltext@MSK | Save
  • Sorafenib (SOR) plus chemotherapy (CRx) in patients (pts) with triple-negative (TN) advanced (adv) breast cancer (BC): Subgroup analyses of 3, double-blind, randomised, placebo (PL)-controlled phase 2b trials from the TIES (Trials to Investigate the Efficacy of Sorafenib) BC program
    Meeting Abstract

    Hudis, C. A.; Baselga, J.; Gradishar, W. J.; Tauer, K. W.; Hermann, R. C.; Gomez, P.; Roche, H.; Kaklamani, V.; Sahoo, T. P.; Schwartzberg, L.
    Annals of Oncology (2011)

    Fulltext@MSK | Save
  • Improved 6-month survival rate in subjects with prostate stem cell antigen positive tumors in a global, randomized phase 2 trial comparing gemcitabine vs. gemcitabine + AGS-1C4D4 (ASP6182) in metastatic pancreatic cancer
    Meeting Abstract

    Hidalgo, M.; O'Reilly, E. M.; Ko, Y. J.; Blaszkowksy, L. S.; Rarick, M. U.; Lima, Cmsr; Ritch, P. S.; Chan, E.; Spratlin, J. L.; Macarulla, T.; more...
    Annals of Oncology (2011)

    Fulltext@MSK | Save
  • Comprehensive oncology measures for peripheral T-cell lymphoma treatment (COMPLETE), a new international treatment registry
    Meeting Abstract

    Foss, F.; Carson, K. R.; Federico, M.; Gisselbrecht, C.; Horwitz, S. M.; Hsi, E. D.; Pinter-Brown, L. C.; Pro, B.; Rosen, S. T.
    Annals of Oncology (2011)

    Fulltext@MSK | Save
  • T-Cell project: An international, prospective, observational study of patients with aggressive peripheral T-cell lymphoma. Analysis of first 524 patients
    Meeting Abstract

    Federico, M.; Bellei, M.; Pesce, E. A.; Zucca, E.; Pileri, S.; Montoto, S.; Weisenburger, D.; Rudiger, T.; Ko, Y.; Liang, R.; more...
    Annals of Oncology (2011)

    Fulltext@MSK | Save